Large gap with delayed quotes
|
Last quote
05/12/2026
-
10:30:34
|
Bid
05/12/2026 -
10:33:40
|
Bid Volume |
Ask
05/12/2026 -
10:31:45
|
Ask Volume |
|---|---|---|---|---|
|
45.94
-1.30
(
-2.75% )
|
45.88
|
116 |
45.96
|
2 |
Analysis date: 08.05.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 01.05.2026.
Interest
Weak
Weak
Two stars since 08.05.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 31.03.2026 at a price of 37.24.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 08.05.2026.
4wk Rel Perf
20.04%
20.04%
The four-week dividend-adjusted overperformance versus STOXX600 is 20.04%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 27.05.2025.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 2.12%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.45%.
Mkt Cap in $bn
1.07
1.07
With a market capitalization <$2bn, REDCARE PHARMACY is considered a small-cap stock.
G/PE Ratio
1.92
1.92
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
24.08
24.08
The estimated PE is for the year 2028.
LT Growth
46.26%
46.26%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
223
223
For 1% of index variation, the stock varies on average by 2.23%.
Correlation
0.43
0.43
43.47% of stock movements are explained by index variations.
Value at Risk
21.77
21.77
The value at risk is estimated at EUR 21.77. The risk is therefore 49.29%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.11.2017
03.11.2017